News archive

The European Commission supports the introduction of individualized computer models and simulations for the development and evaluation of drugs and medical devices.

Forbes recently published an article "The future of Clinical Trials? Here is a simulation model of the heart" that presents the great results achieved by the Living Heart Project towards the development of an extensive computer simulation model of the human heart that can then be used to test different types of devices and medications and train people how to do different procedures.

In a project funded by the PETA International Science Consortium Ltd., scientists from the Institute of Biochemistry, Biotechnology and Bioinformatics at the Technical University of Braunschweig, Germany, as well as from the British National Institute for Biological Standards and Control (NIBSC), have developed human antibodies that neutralize the diphtheria toxin.

Graduate Fellowships Available from IFER

Monday, 20 January 2020 13:10

The International Foundation for Ethical Research (IFER), located in Chicago, Illinois, is accepting applications for graduate fellowships.

A research team from the Technical University of Hamburg (TUHH) and from the University Hospital Eppendorf (UKE), Hamburg, has developed a new method to eliminate the need for animal experiments for the treatment simulation of cerebrovascular aneurysms.

A research alliance consisting of Leipzig University Medicine,  and KET GmbH has developed a new, silicone-based 3D cell culture structure to create optimal conditions for cell growth outside the organism.

Totipotent-like cells generated in a new way

Wednesday, 15 January 2020 16:25

A research group at Helmholtz Zentrum München has discovered that specific metabolites can stimulate the formation of totipotent-like cells from pluripotent cells. These findings open up new possibilities for cell reprogramming.

Munich: New imaging method developed

Wednesday, 15 January 2020 15:08

Scientists at the Technical University of Munich have developed a new imaging technique that enables a marker-free observation of metabolic processes in living cells in real time.

A research team headed by the Paul Ehrlich Institute in Langen, Germany, has generated induced pluripotent stem cells (iPSC) from a healthy person and two people with rare monogenetic diseases. By comparing the cells between healthy and sick people, it is possible to gain important insights into the processes involved in diseases and the immune response against HIV.

Researchers at the University of Kaiserslautern are working to improve the viability of 3D printed cells. For this purpose, they are developing a micro-electromechanical system, whose electric fields are influencing the growing cells.

Page 1 of 56